State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...
No significant improvement seen in overall survival with addition of hormone therapy to post-radical prostatectomy radiotherapy.
Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...
15h
Clinical trial at Cleveland hospital leads to practice-changing precision prostate cancer therapy
A groundbreaking randomized clinical trial led by Chair of Radiation Oncology Daniel Spratt at University Hospitals Seidman ...
Cardiovascular disease is the second leading cause of death among cancer survivors, second only to cancer itself. The same treatments that can save patients from cancer may also r ...
A former Rosyth dockyard worker has revealed the 'horrendous' experience of his prostate cancer to encourage men to get tested. Alex Keatings, 68, who worked for decades as a manager for the aircraft ...
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple ...
Tagawa, MD, identified 3 primary clinical scenarios where PSMA PET scans have become the established standard for prostate ...
Historically, treatment for metastatic prostate cancer relied heavily on androgen deprivation therapy (ADT) alone. Over time, ...
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...
Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results